Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Albiglutide

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

GSK · Phase 3 · Completed · Enrollment 507

NCT01098539

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.